Venture firm Flagship bets £100 million to build AI-driven drug companies in Britain
Reuters

Venture firm Flagship bets £100 million to build AI-driven drug companies in Britain

By Bhanvi Satija LONDON, Nov 16 (Reuters) - Flagship Pioneering is opening its first lab for creating companies outside the United States, putting £100 million ($131.94 million) behind a new UK-based effort to fund and build AI-driven biotech companies, the venture firm said on Monday. The move is a
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.